New decisions were published in the cases of Purdue Pharma v. Canada (Attorney General) 2011 FCA 132 (Oxycodone), Apotex Inc. v. Allergan, Inc. 2011 FCA 134 (Gatifloxacin) and Varco Canada Limited v. Pason Systems Corp. 2011 FC 467.
Continue reading FC and FCA release new decisions
Yesterday, the United States Supreme Court heard oral arguments in the Microsoft v. i4i patent case in the United States. Microsoft appealed to the Supreme Court, arguing that the standard of proof needed to invalidate an asserted patent is too high. Patently-O has a summary of the oral arguments.
In today’s Canada Gazette, amendments to the Patented Medicine (Notice of Compliance) Regulations were published relating to ‘Extraordinary Use New Drugs’ (EUNDs). Changes were also made to the regulations under the Food and Drugs Act.
For those interested, I have compiled a list of Canadian patent firms/agents by volume of applications published (or entered national phase) in 2010.
Amazon.com filed its Responding Memorandum of Fact and Law earlier this week (PDF available) in the proceeding on patentable subject matter at the Federal Court of Appeal.
For those interested, I have compiled a list of Canadian trademark firms/agents by volume of applications filed in 2010.
Yesterday, the Canadian Life and Health Insurance Association Inc. and the Canadian Bankers Association filed a motion to intervene (PDF available) in the Amazon.com proceeding on patentable subject matter at the Federal Court of Appeal.
Amendments to the Patent Rules relating to advanced examination of ‘green technologies’ (s.28(1)(b)) were published in the Canada Gazette and are now in force. The amendments also provide for all applications to leave advanced examination if time limits are extended or the application goes abandoned (s.28(2)).
For those interested, a copy of the Appellants’ Memo of Fact and Law on the Amazon.com appeal on patentable subject that was filed yesterday is available from my website.
The government filed a Notice of Appeal (PDF) today against Justice Phelan’s decision in Amazon.com regarding the patentability of business methods.